Published in Curr Mol Med on June 01, 2009
Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell (2011) 2.04
A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors. Cancer Biol Ther (2011) 1.76
Potential therapeutic implications of cancer stem cells in glioblastoma. Biochem Pharmacol (2010) 1.60
Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting. Protein Cell (2010) 1.45
Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment. Clin Dev Immunol (2011) 1.24
Brain tumor stem cells: Molecular characteristics and their impact on therapy. Mol Aspects Med (2013) 1.14
The Wnt secretion protein Evi/Gpr177 promotes glioma tumourigenesis. EMBO Mol Med (2011) 1.10
Emerging insights into barriers to effective brain tumor therapeutics. Front Oncol (2014) 1.08
Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis. Herpesviridae (2011) 1.05
Bufalin induces the interplay between apoptosis and autophagy in glioma cells through endoplasmic reticulum stress. Int J Biol Sci (2014) 0.95
Control of glioblastoma tumorigenesis by feed-forward cytokine signaling. Nat Neurosci (2016) 0.95
Therapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms. J Cell Mol Med (2013) 0.95
Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures. Cell Cycle (2013) 0.95
Metabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficacies. PLoS One (2011) 0.91
ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro. Neuro Oncol (2013) 0.91
iNOS: a potential therapeutic target for malignant glioma. Curr Mol Med (2013) 0.89
STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and Transformation. J Neurosci (2012) 0.87
Metformin inhibits leptin-induced growth and migration of glioblastoma cells. Oncol Lett (2012) 0.83
Blockade of glioma proliferation through allosteric inhibition of JAK2. Sci Signal (2013) 0.83
Multivariate signaling regulation by SHP2 differentially controls proliferation and therapeutic response in glioma cells. J Cell Sci (2014) 0.82
The Role of STAT3 in Thyroid Cancer. Cancers (Basel) (2014) 0.80
Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma. PLoS One (2015) 0.80
Inositol Polyphosphate-5-Phosphatase F (INPP5F) inhibits STAT3 activity and suppresses gliomas tumorigenicity. Sci Rep (2014) 0.79
A single nucleotide polymorphism in the 3'-UTR of STAT3 regulates its expression and reduces risk of pancreatic cancer in a Chinese population. Oncotarget (2016) 0.78
PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals. Oncotarget (2016) 0.78
DARPP32, STAT5 and STAT3 mRNA expression ratios in glioblastomas are associated with patient outcome. Pathol Oncol Res (2012) 0.78
Glioblastoma: exosome and microRNA as novel diagnosis biomarkers. Cancer Gene Ther (2016) 0.75
Nuclear factor one B (NFIB) encodes a subtype-specific tumour suppressor in glioblastoma. Oncotarget (2016) 0.75
Inhibition of Autophagy by Chloroquine Enhances the Antitumor Efficacy of Sorafenib in Glioblastoma. Cell Mol Neurobiol (2016) 0.75
Sinomenine Hydrochloride Inhibits Human Glioblastoma Cell Growth through Reactive Oxygen Species Generation and Autophagy-Lysosome Pathway Activation: An In Vitro and In Vivo Study. Int J Mol Sci (2017) 0.75
The hallmarks of cancer. Cell (2000) 113.05
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55
Identification of human brain tumour initiating cells. Nature (2004) 38.87
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (1997) 29.34
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (1994) 26.02
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
Stat3 as an oncogene. Cell (1999) 17.39
Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev (2007) 17.20
STATs and gene regulation. Science (1997) 16.55
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. N Engl J Med (2005) 15.42
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet (1997) 15.38
Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature (2006) 7.69
Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol (2001) 7.22
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. Nat Med (2005) 6.45
A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. Science (1993) 6.44
Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell (2002) 5.11
Mosaic organization of neural stem cells in the adult brain. Science (2007) 5.05
What does Stat3 do? J Clin Invest (2002) 4.83
Stat proteins and oncogenesis. J Clin Invest (2002) 4.79
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma. Neuron (2007) 4.47
Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science (1997) 4.26
Molecular pathology of malignant gliomas. Annu Rev Pathol (2006) 4.24
Pten haploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res (2008) 3.99
Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature (1996) 3.88
Epigenetic-mediated dysfunction of the bone morphogenetic protein pathway inhibits differentiation of glioblastoma-initiating cells. Cancer Cell (2008) 3.87
STAT proteins: novel molecular targets for cancer drug discovery. Oncogene (2000) 3.75
Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. J Clin Invest (2004) 3.70
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway. Cancer Cell (2005) 3.67
A low-molecular-weight compound discovered through virtual database screening inhibits Stat3 function in breast cancer cells. Proc Natl Acad Sci U S A (2005) 3.46
A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J (1996) 3.40
Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level. Mol Cell Biol (1993) 3.37
Analysis of the phosphatidylinositol 3'-kinase signaling pathway in glioblastoma patients in vivo. Cancer Res (2003) 3.36
Phosphotyrosyl peptides block Stat3-mediated DNA binding activity, gene regulation, and cell transformation. J Biol Chem (2001) 3.27
Two contact regions between Stat1 and CBP/p300 in interferon gamma signaling. Proc Natl Acad Sci U S A (1996) 3.26
Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol (2004) 3.25
Gliomagenesis: genetic alterations and mouse models. Nat Rev Genet (2001) 3.13
Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev (1999) 2.91
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature (1998) 2.83
STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity (2002) 2.77
Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene (2002) 2.69
Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res (1995) 2.67
STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc Natl Acad Sci U S A (1996) 2.64
Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev (2008) 2.61
Targeted disruption of the low-affinity leukemia inhibitory factor receptor gene causes placental, skeletal, neural and metabolic defects and results in perinatal death. Development (1995) 2.46
Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. Cancer Res (2002) 2.45
Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J Biol Chem (1996) 2.39
Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. Proc Natl Acad Sci U S A (2003) 2.35
Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity. Cancer Res (2003) 2.30
Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia (2008) 2.23
The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature (2004) 2.22
Knockdown of STAT3 expression by RNA interference inhibits the induction of breast tumors in immunocompetent mice. Cancer Res (2005) 2.20
Cell fate specification in the mammalian telencephalon. Prog Neurobiol (2007) 1.99
Discovery of a novel shp2 protein tyrosine phosphatase inhibitor. Mol Pharmacol (2006) 1.98
Multiple routes to astrocytic differentiation in the CNS. J Neurosci (1998) 1.97
Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation. Mol Endocrinol (1996) 1.86
Signal transducers and activators of transcription 3 (STAT3) inhibits transcription of the inducible nitric oxide synthase gene by interacting with nuclear factor kappaB. Biochem J (2002) 1.86
Knockdown of STAT3 expression by RNAi induces apoptosis in astrocytoma cells. BMC Cancer (2003) 1.85
STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity (2001) 1.81
Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood (1994) 1.78
The Jak-Stat pathway in normal and perturbed hematopoiesis. Blood (2000) 1.78
Neural stem cell self-renewal. Crit Rev Oncol Hematol (2007) 1.76
IL-6 is required for glioma development in a mouse model. Oncogene (2004) 1.74
Identification and characterization of signal transducer and activator of transcription 3 recruitment sites within the epidermal growth factor receptor. Cancer Res (2003) 1.73
The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transducer and activator of transcription (STAT) family. Mol Cell Biol (1994) 1.67
Randomized phase II study of temozolomide and radiotherapy compared with radiotherapy alone in newly diagnosed glioblastoma multiforme. J Clin Oncol (2005) 1.61
BMPs signal alternately through a SMAD or FRAP-STAT pathway to regulate fate choice in CNS stem cells. J Cell Biol (2003) 1.59
Notch signaling promotes astrogliogenesis via direct CSL-mediated glial gene activation. J Neurosci Res (2002) 1.58
Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking. Proc Natl Acad Sci U S A (2008) 1.54
IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff. Nat Cell Biol (2002) 1.51
Malignant transformation but not normal cell growth depends on signal transducer and activator of transcription 3. Cancer Res (2005) 1.49
Control of myeloid differentiation and survival by Stats. Oncogene (2000) 1.42
STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells . Prostate (2000) 1.40
Constitutive activation of Stat3alpha in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2). Oncogene (2002) 1.39
The state of the STATs: recent developments in the study of signal transduction to the nucleus. Curr Opin Cell Biol (1997) 1.38
Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J Neurosci (2008) 1.36
Small molecule inhibitors of Stat3 signaling pathway. Curr Cancer Drug Targets (2007) 1.35
p300/CBP is required for transcriptional induction by interleukin-4 and interacts with Stat6. Nucleic Acids Res (1999) 1.31
Glioblastoma cells do not intravasate into blood vessels. Neurosurgery (1995) 1.27
Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice. BMC Cancer (2007) 1.26
Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1. Oncogene (1999) 1.24
Non-cell-autonomous action of STAT3 in maintenance of neural precursor cells in the mouse neocortex. Development (2006) 1.24
Role of metazoan mediator proteins in interferon-responsive transcription. Mol Cell Biol (2003) 1.22
STAT3 mediates IL-6-induced growth inhibition in the human prostate cancer cell line LNCaP. Prostate (2000) 1.19
JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3. J Biol Chem (2005) 1.18
Design, synthesis, and studies of small molecule STAT3 inhibitors. Bioorg Med Chem Lett (2007) 1.18
Differential activation of STATs 3 and 5 during mammary gland development. FEBS Lett (1996) 1.17
The STAT3 DNA-binding domain mediates interaction with NF-kappaB p65 and inducible nitric oxide synthase transrepression in mesangial cells. J Am Soc Nephrol (2004) 1.17
STAT3-mediated differentiation and survival and of myeloid cells in response to granulocyte colony-stimulating factor: role for the cyclin-dependent kinase inhibitor p27(Kip1). Oncogene (2000) 1.16
Inhibition of Stat3 increases doxorubicin sensitivity in a human metastatic breast cancer cell line. Cancer Lett (2007) 1.14
STAT proteins: signal tranducers and activators of transcription. Methods Enzymol (2001) 1.12
Aberrant receptor signaling in human malignant gliomas: mechanisms and therapeutic implications. Cancer Lett (2001) 1.11
Cooperation of the transcriptional coactivators CBP and p300 with Stat6. J Interferon Cytokine Res (1999) 1.04
Cucurbitacin I inhibits Stat3 and induces apoptosis in Sézary cells. J Invest Dermatol (2008) 1.01
Glioblastoma multiforme and the epidermal growth factor receptor. N Engl J Med (2005) 1.00
Signaling pathways regulating gliomagenesis. Curr Mol Med (2003) 0.99
Requirement of STAT3 activation for differentiation of mucosal stratified squamous epithelium. Mol Med (2003) 0.92
Cytokine gene expression on glioma cell lines and specimens. J Neurooncol (1994) 0.91
The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell (2007) 6.04
SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell (2008) 5.76
A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span. Cell (2006) 5.36
A calcium-regulated MEF2 sumoylation switch controls postsynaptic differentiation. Science (2006) 4.42
Cdh1-APC controls axonal growth and patterning in the mammalian brain. Science (2004) 3.44
Degradation of Id2 by the anaphase-promoting complex couples cell cycle exit and axonal growth. Nature (2006) 3.31
A CaMKII-NeuroD signaling pathway specifies dendritic morphogenesis. Neuron (2004) 2.62
Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. Genes Dev (2008) 2.61
A centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmitotic neurons. Cell (2009) 2.21
Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes. Mol Cell Biol (2005) 2.20
Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc Natl Acad Sci U S A (2004) 2.03
Cell-intrinsic regulation of axonal morphogenesis by the Cdh1-APC target SnoN. Neuron (2006) 1.98
Cdc2 phosphorylation of BAD links the cell cycle to the cell death machinery. Mol Cell (2002) 1.90
JNK phosphorylation and activation of BAD couples the stress-activated signaling pathway to the cell death machinery. J Biol Chem (2002) 1.80
A CaMKIIβ signaling pathway at the centrosome regulates dendrite patterning in the brain. Nat Neurosci (2011) 1.80
Cell cycle regulation of neuronal apoptosis in development and disease. Prog Neurobiol (2004) 1.75
p38 MAP kinase mediates apoptosis through phosphorylation of BimEL at Ser-65. J Biol Chem (2006) 1.64
Activation of FOXO1 by Cdk1 in cycling cells and postmitotic neurons. Science (2008) 1.56
Regulation of neuronal cell death by MST1-FOXO1 signaling. J Biol Chem (2009) 1.51
brawn for brains: the role of MEF2 proteins in the developing nervous system. Curr Top Dev Biol (2005) 1.44
TGFbeta-Smad2 signaling regulates the Cdh1-APC/SnoN pathway of axonal morphogenesis. J Neurosci (2008) 1.42
A Cdc20-APC ubiquitin signaling pathway regulates presynaptic differentiation. Science (2009) 1.40
An OBSL1-Cul7Fbxw8 ubiquitin ligase signaling mechanism regulates Golgi morphology and dendrite patterning. PLoS Biol (2011) 1.40
RNA interference reveals a requirement for myocyte enhancer factor 2A in activity-dependent neuronal survival. J Biol Chem (2002) 1.38
Deregulation of a STAT3-interleukin 8 signaling pathway promotes human glioblastoma cell proliferation and invasiveness. J Neurosci (2008) 1.36
Apoptosis induced by p75NTR overexpression requires Jun kinase-dependent phosphorylation of Bad. J Neurosci (2003) 1.36
The E2F-Cdc2 cell-cycle pathway specifically mediates activity deprivation-induced apoptosis of postmitotic neurons. J Neurosci (2003) 1.30
Characterization of a neurotrophin signaling mechanism that mediates neuron survival in a temporally specific pattern. J Neurosci (2003) 1.27
Cultures of cerebellar granule neurons. CSH Protoc (2008) 1.27
The transcription factor NFAT3 mediates neuronal survival. J Biol Chem (2004) 1.27
A FOXO-Pak1 transcriptional pathway controls neuronal polarity. Genes Dev (2010) 1.27
A molecular basis for phosphorylation-dependent SUMO conjugation by the E2 UBC9. Nat Struct Mol Biol (2009) 1.26
Pin1 mediates neural-specific activation of the mitochondrial apoptotic machinery. Neuron (2006) 1.25
Thinking within the D box: initial identification of Cdh1-APC substrates in the nervous system. Mol Cell Neurosci (2007) 1.25
Characterization of the c-Jun N-terminal kinase-BimEL signaling pathway in neuronal apoptosis. J Neurosci (2004) 1.24
Microparticle-based delivery of oxytocin receptor antisense DNA in the medial amygdala blocks social recognition in female mice. Proc Natl Acad Sci U S A (2007) 1.21
Formulation and characterization of poly (beta amino ester) microparticles for genetic vaccine delivery. J Control Release (2005) 1.20
Transcriptional regulation of neuronal polarity and morphogenesis in the mammalian brain. Neuron (2011) 1.19
PIASx is a MEF2 SUMO E3 ligase that promotes postsynaptic dendritic morphogenesis. J Neurosci (2007) 1.19
The dynamic ubiquitin ligase duo: Cdh1-APC and Cdc20-APC regulate neuronal morphogenesis and connectivity. Curr Opin Neurobiol (2010) 1.14
FoxO6 regulates memory consolidation and synaptic function. Genes Dev (2012) 1.14
Cystatin B deficiency sensitizes neurons to oxidative stress in progressive myoclonus epilepsy, EPM1. J Neurosci (2009) 1.12
A SnoN-Ccd1 pathway promotes axonal morphogenesis in the mammalian brain. J Neurosci (2009) 1.09
ING2 as a novel mediator of transforming growth factor-beta-dependent responses in epithelial cells. J Biol Chem (2008) 1.08
Cell-intrinsic drivers of dendrite morphogenesis. Development (2013) 1.06
Moving past proliferation: new roles for Cdh1-APC in postmitotic neurons. Trends Neurosci (2005) 1.04
Transcription factor Sp4 regulates dendritic patterning during cerebellar maturation. Proc Natl Acad Sci U S A (2007) 1.03
A JIP3-regulated GSK3β/DCX signaling pathway restricts axon branching. J Neurosci (2010) 1.03
Beyond proliferation--cell cycle control of neuronal survival and differentiation in the developing mammalian brain. Semin Cell Dev Biol (2005) 0.97
The X-linked intellectual disability protein PHF6 associates with the PAF1 complex and regulates neuronal migration in the mammalian brain. Neuron (2013) 0.96
A TRPC5-regulated calcium signaling pathway controls dendrite patterning in the mammalian brain. Genes Dev (2011) 0.96
Spatial organization of ubiquitin ligase pathways orchestrates neuronal connectivity. Trends Neurosci (2013) 0.96
Novel functions for the anaphase-promoting complex in neurobiology. Semin Cell Dev Biol (2011) 0.94
Cell intrinsic control of axon regeneration. EMBO Rep (2014) 0.94
Pin1 in neuronal apoptosis. Cell Cycle (2007) 0.94
A conserved PTEN/FOXO pathway regulates neuronal morphology during C. elegans development. Development (2011) 0.94
An isoform-specific SnoN1-FOXO1 repressor complex controls neuronal morphogenesis and positioning in the mammalian brain. Neuron (2011) 0.93
Regulation of Cdh1-APC function in axon growth by Cdh1 phosphorylation. J Neurosci (2009) 0.92
Sumoylated MEF2A coordinately eliminates orphan presynaptic sites and promotes maturation of presynaptic boutons. J Neurosci (2013) 0.89
STAT3-iNOS Signaling Mediates EGFRvIII-Induced Glial Proliferation and Transformation. J Neurosci (2012) 0.87
Identification of a Novel Link between the Protein Kinase NDR1 and TGFβ Signaling in Epithelial Cells. PLoS One (2013) 0.86
The ubiquitin receptor S5a/Rpn10 links centrosomal proteasomes with dendrite development in the mammalian brain. Cell Rep (2013) 0.86
FLEXIQinase, a mass spectrometry-based assay, to unveil multikinase mechanisms. Nat Methods (2012) 0.86
Modeling oxidative stress in the central nervous system. Curr Mol Med (2006) 0.85
Destroy to create: E3 ubiquitin ligases in neurogenesis. F1000 Biol Rep (2010) 0.83
Molecular control of axon branching. Neuroscientist (2011) 0.83
SnoN signaling in proliferating cells and postmitotic neurons. FEBS Lett (2012) 0.83
Phosphorylation of BAD at Ser-128 during mitosis and paclitaxel-induced apoptosis. FEBS Lett (2005) 0.82
Demystifying MST family kinases in cell death. Curr Mol Med (2008) 0.81
Cdk1-FOXO1: a mitotic signal takes center stage in post-mitotic neurons. Cell Cycle (2008) 0.80
A novel Hap1-Tsc1 interaction regulates neuronal mTORC1 signaling and morphogenesis in the brain. J Neurosci (2013) 0.79
The XLID protein PQBP1 and the GTPase Dynamin 2 define a signaling link that orchestrates ciliary morphogenesis in postmitotic neurons. Cell Rep (2013) 0.78
An old dog learns new tricks: a novel function for Cdc20-APC in dendrite morphogenesis in neurons. Cell Cycle (2010) 0.78
Combinatorial assembly of neurons: from chromatin to dendrites. Trends Cell Biol (2008) 0.77
Cochlear implant outcomes in patients with superior canal dehiscence. Cochlear Implants Int (2013) 0.77
SnoN facilitates axonal regeneration after spinal cord injury. PLoS One (2013) 0.77
Releasing the brake on presynaptic development: Cdc20-APC triggers NeuroD2 degradation to drive presynaptic differentiation. Cell Cycle (2010) 0.76
Influence of trainee participation on operative times for adult and pediatric cochlear implantation. Cochlear Implants Int (2014) 0.75
Auditory Brainstem Implant Array Position Varies Widely Among Adult and Pediatric Patients and Is Associated With Perception. Ear Hear (2017) 0.75